A microfluidic device for real-time on-demand intravenous oxygen delivery

Area of Science:

• Biomedical Engineering
• Cardiopulmonary Physiology
• Medical Devices

Background:

• Refractory hypoxemia poses a critical threat, often leading to organ dysfunction and mortality.
• Current treatments require specialized equipment and intensive care, with limited success in severe cases.

Purpose of the Study:

• To introduce a novel microfluidic device for real-time, on-demand oxygen administration directly into the bloodstream.
• To explore a new strategy for managing hypoxemia refractory to standard care.

Main Methods:

• Development of a microfluidic device utilizing sequential shear-induced bubble breakup.
• In vitro and/or in vivo testing of the device for oxygen delivery and physiological impact (details not provided in abstract).

Main Results:

• The microfluidic device successfully administers oxygen gas directly to the bloodstream.
• The technology demonstrates potential for stabilizing patients with refractory hypoxemia.

Conclusions:

• This microfluidic oxygenation strategy offers a promising alternative for treating severe hypoxemia.
• The technology may mitigate organ damage and reduce ventilator-related lung injury in critically ill patients.